The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide Angiocardiography
Abstract
We measured cardiac performance sequentially, using quantitative radionuclide angiocardiography to estimate left ventricular ejection fraction in 55 patients receiving doxorubicin for treatment of cancer. With final doxorubicin dosages greater than 350 mg per square meter, the lowest ejection fraction measured was significantly less than the initial determination. Five patients had severe cardiotoxicity (congestive heart failure). All had an ejection fraction of less than 30 per cent at the time of heart failure, and demonstrated moderate cardiotoxicity (a decline in ejection fraction by at least 15 per cent to a final value of less than 45 per cent) before clinical manifestations. Six patients with moderate toxicity in whom doxorubicin was discontinued did not have heart failure or a further decline in ejection fraction during the follow-up period. Moderate toxicity was continued, but mild toxicity (decline of ejection fraction by greater than 10 per cent, noted in 11 patients) was not well predicted. The assessment of radionuclide left ventricular ejection fraction during doxorubicin therapy may make it possible to avoid congestive heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
- STATISTICAL PACKAGE FOR SOCIAL SCIENCES
(2014) · Statistical Methods in Psychiatry Research and SPSS · doi:10.1201/b17560-26 · Cited by 12,056
A clinicopathologic analysis of adriamycin cardiotoxicity
Lefrak, E. A., Piťha, J., Rosenheim, S., & Gottlieb, J. A. (1973) · Cancer · doi:10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2 · Cited by 1,560
Adriamycin: A New Anticancer Drug with Significant Clinical Activity
BLUM, R. H., & CARTER, S. K. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-2-249 · Cited by 1,057
Borer, J. S., Bacharach, S. L., Green, M. V., Kent, K. M., Epstein, S. E., Johnston, G. S., & Mack, B. (1977) · New England Journal of Medicine · doi:10.1056/nejm197704142961503 · Cited by 773
GARRARD, C. L., WEISSLER, A. M., & DODGE, H. T. (1970) · Circulation · doi:10.1161/01.cir.42.3.455 · Cited by 450
BRISTOW, M. R., MASON, J. W., BILLINGHAM, M. E., & DANIELS, J. R. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-88-2-168 · Cited by 417
Adriamycin (NSC 123127) cardiomyopathy. An overview with determination of risk factors
Minow, R. A., Benjamin, R. S., & Gottlieb, J. A. (1975) · Cited by 274
HEART DISEASE FOLLOWING RADIATION
COHN, K. E., STEWART, J. R., FAJARDO, L. F., & HANCOCK, E. W. (1967) · Medicine · doi:10.1097/00005792-196705000-00003 · Cited by 257
Adriamycin cardiomyopathy—risk factors
Minow, R. A., Benjamin, R. S., Lee, E. T., & Gottlieb, J. A. (1977) · Cancer · doi:10.1002/1097-0142(197704)39:4<1397::aid-cncr2820390407>3.0.co;2-u · Cited by 251
Global and regional left ventricular response to bicycle exercise in coronary artery disease
Berger, H. J., Reduto, L. A., Johnstone, D. E., Borkowski, H., Sands, J. M., Cohen, L. S., Langou, R. A., Gottschalk, A., & Zaret, B. L. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90476-5 · Cited by 216
Self-citationREDUTO, L. A., BERGER, H. J., COHEN, L. S., GOTTSCHALK, A., & ZARET, B. L. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-4-441 · Cited by 200
Self-citationAdriamycin Cardiotoxicity in Man
RINEHART, J. J., LEWIS, R. P., & BALCERZAK, S. P. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-475 · Cited by 190
Matthay, R. A., Berger, H. J., Loke, J. S. O., GOTTSCHALK, A. R., & Zaret, B. L. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90741-6 · Cited by 140
Self-citationEvaluation of cardiac function during adriamycin therapy
Burg, J. R., Moseley, H. S., Lindell, T. D., Kremkau, E. L., & Fletcher, W. S. (1974) · Journal of Surgical Oncology · doi:10.1002/jso.2930060607 · Cited by 9
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Metadata
- Authors
- Alexander, J., Dainiak, N., Berger, H. J., Goldman, L., Johnstone, D., Reduto, L., Duffy, T., Schwartz, P., Gottschalk, A., Zaret, B. L., & Pytlik, L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1979-02-08
- Volume
- 300
- Issue
- 6
- Pages
- 278-283
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2049129583
- Cited by
- 535
- References
- 14
- FWCI
- 20.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.